Placebo «Spiruline plus» Detail if Abnormal Placebo «Spiruline plus»
General device          
Abnormal 1 (1.7%) 1 (1.8%) cachexy 1 1
Normale 58 (98.3%) 53 (98.2%)      
ORP          
Abnormal - 1 (1.8%) decrease visual acuity   1
Normale 59 (100%) 53 (98.2%)      
pulmonary          
Abnormal - 2 (3.7%) pulmonary   2
Normale 59 (100%) 52 (96.3%)      
cardiovascular          
Abnormal - -      
Normale 59 (100%) 54 (100%)      
digestive          
Abnormal - 2 (3.7%) Abdominal pain   1
Normale 59 (100%) 52 (96.3%)     1
neurological          
Abnormal - 2 (3.7%) Céphalées+Paresthésie   1
Normale 59 (100%) 52 (96.3%) neuropathy ringroad   1
lymphatic          
Abnormal - -      
Normale 59 (100%) 54 (100%)      
endocrine          
Abnormal - -      
Normale 59 (100%) 54 (100%)      
Musculoskeletal         1
Abnormal - 3 (3.6%) pains broadcast   1
Normale 59 (100%) 51 (94.4%)  limping   1
Urogénital          
Abnormal - -      
Normale 59 (100%) 54 (100%)      
Dermatologie          
Anormale 1 (1.7%) 2 (3.8%) keratoderma   1
Normale 58 (98.3%) 51 (96.2%) prurigo 1  
ORP: Oto Rhino pharyngeal.
Table 4: Clinical Events at 6 months follow-up of patients according to the treatment and placebo “Spiruline plus”.